Valuation: Clover Corporation Limited

Market Cap 155M 109M 95.37M 88.69M 81.39M 153M 10.46B 1.05B 411M 5.14B 408M 399M 17.78B P/E 2026 *
15x
P/E 2027 * 10.9x
Enterprise Value 153M 107M 93.96M 87.38M 80.18M 151M 10.3B 1.04B 405M 5.06B 402M 393M 17.51B EV / Sales 2026 *
1.63x
EV / Sales 2027 * 1.28x
Free-Float
76.93%
Yield 2026 *
-
Yield 2027 * -
1 day+6.25%
1 week+8.72%
Current month+10.65%
1 month+10.00%
3 months-6.50%
6 months+19.11%
Current year+18.35%
1 week 0.83
Extreme 0.83
0.94
1 month 0.7
Extreme 0.7
0.94
Current year 0.7
Extreme 0.7
1.16
1 year 0.52
Extreme 0.525
1.16
3 years 0.34
Extreme 0.337
1.16
5 years 0.34
Extreme 0.337
1.8
10 years 0.34
Extreme 0.337
3.31
Manager TitleAgeSince
Chief Executive Officer - 11/11/2014
Director of Finance/CFO - 06/05/2021
Chief Operating Officer - 03/02/2011
Director TitleAgeSince
Director/Board Member - 11/11/2014
Chairman - 21/09/2017
Director/Board Member - 01/02/2017
Date Insider Type Main position Quantity % Market Cap.
18/11/25 Buy

Chief Executive Officer

529,638 0.3171%
18/11/25 Sell

Chief Executive Officer

255,199 0.1528%
6/11/25 Buy

Chief Financial Officer

2,447 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
+6.25%+8.72%+61.21%-14.61% 102M
-6.33%+1.88%+32.34%+79.76% 13.49B
-4.43%-3.53%-29.24%+239.05% 7.59B
-3.29%-3.58%-18.01%-53.92% 2.4B
+1.60%-1.47%+23.90%-26.07% 1.23B
+2.20%+0.93%+22.80%+39.52% 1.2B
-3.36%-10.68%-32.72%-31.25% 1.19B
-2.40%-17.21%-49.07% - 1.18B
+3.57%-3.39%-67.10%-71.52% 904M
-4.46%-7.79%-33.69%-9.75% 709M
Average -1.01%-4.39%-8.96%+16.80% 3B
Weighted average by Cap. -4.26%-4.80%+1.77%+92.50%

Financials

2026 *2027 *
Net sales 94M 65.73M 57.73M 53.69M 49.27M 92.57M 6.33B 638M 249M 3.11B 247M 241M 10.76B 116M 81.19M 71.31M 66.32M 60.85M 114M 7.82B 787M 308M 3.84B 305M 298M 13.29B
Net income 9.8M 6.85M 6.02M 5.6M 5.14M 9.65M 660M 66.47M 25.97M 324M 25.73M 25.17M 1.12B 13.5M 9.44M 8.29M 7.71M 7.08M 13.3M 909M 91.57M 35.77M 447M 35.44M 34.68M 1.55B
Net Debt -2.3M -1.61M -1.41M -1.31M -1.21M -2.27M -155M -15.6M -6.09M -76.15M -6.04M -5.91M -263M -7.2M -5.03M -4.42M -4.11M -3.77M -7.09M -485M -48.84M -19.08M -238M -18.9M -18.49M -824M
Logo Clover Corporation Limited
Clover Corporation Limited focused on technology, new product development, and commercialization. The principal activities of the Company are the refining and sale of natural oils, the production of encapsulated powders and the research and product development of functional food and infant nutrition ingredients. Its microencapsulation technology enables nutritional oils, such as tuna, fish, algal and fungal oils, to be added to infant formulas, foods, and beverages. Its technologies protect those sensitive oils from oxidation, allowing them to be incorporated into a range of applications. The Company, through its subsidiary, Nu-Mega Ingredients Pty Limited (Nu-Mega), supplies refined Omega-3 oils and a range of other encapsulated ingredients for use in infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. Nu-Mega’s Driphorm range of microencapsulated powders enables the addition of Hi-DHA tuna and/or algal oils to a broad spectrum of products.
Employees
68
Date Price Change Volume
27/07/26 $0.9350 +6.25% 74,895
24/07/26 $0.8800 +1.73% 52,788
23/07/26 $0.8650 -2.81% 163,339
22/07/26 $0.8900 +2.30% 859
21/07/26 $0.8700 +1.16% 13,224
Trader
-
Investor
Global
-
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.8800AUD
Average target price
1.280AUD
Spread / Average Target
+45.45%

Annual profits - Rate of surprise